Al-Hendy A - Search Results

1

H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.

Cao T, Jiang Y, Wang Z, Zhang N, Al-Hendy A, Mamillapalli R, Kallen AN, Kodaman P, Taylor HS, Li D, Huang Y. Cao T, et al. Oncogene. 2019 Jul;38(27):5356-5366. doi: 10.1038/s41388-019-0808-4. Epub 2019 May 15. Oncogene. 2019. PMID: 31089260 Free PMC article.

2

Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas.

Nair S, Curiel DT, Rajaratnam V, Thota C, Al-Hendy A. Nair S, et al. Hum Reprod. 2013 Sep;28(9):2398-406. doi: 10.1093/humrep/det275. Epub 2013 Jul 2. Hum Reprod. 2013. PMID: 23820419 Free PMC article.

3

The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer.

Yang Q, Al-Hendy A. Yang Q, et al. Cells. 2022 Mar 29;11(7):1149. doi: 10.3390/cells11071149. Cells. 2022. PMID: 35406713 Free PMC article. Review.

4

Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.

Donnez J, Taylor HS, Stewart EA, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland JP, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E. Donnez J, et al. Lancet. 2022 Sep 17;400(10356):896-907. doi: 10.1016/S0140-6736(22)01475-1. Lancet. 2022. PMID: 36116480 Clinical Trial.

5

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.

Siblini H, Al-Hendy A, Segars J, González F, Taylor HS, Singh B, Flaminia A, Flores VA, Christman GM, Huang H, Johnson JJ, Zhang H. Siblini H, et al. Nutrients. 2023 Jan 9;15(2):320. doi: 10.3390/nu15020320. Nutrients. 2023. PMID: 36678191 Free PMC article. Clinical Trial.

6

Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids.

Yang Q, Al-Hendy A. Yang Q, et al. Int J Mol Sci. 2023 Mar 17;24(6):5778. doi: 10.3390/ijms24065778. Int J Mol Sci. 2023. PMID: 36982852 Free PMC article. Review.

7

Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids.

Yang Q, Ali M, Bariani MV, Vafaei S, Al-Hendy A. Yang Q, et al. Sci Prog. 2023 Oct-Dec;106(4):368504231215601. doi: 10.1177/00368504231215601. Sci Prog. 2023. PMID: 38189295 Free PMC article.

8

Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids.

Al-Hendy A, Segars JH, Taylor HS, González F, Siblini H, Zamah M, Alkelani H, Singh B, Flores VA, Christman GM, Johnson JJ, Huang H, Zhang H. Al-Hendy A, et al. BMJ Open. 2024 Jan 12;14(1):e078989. doi: 10.1136/bmjopen-2023-078989. BMJ Open. 2024. PMID: 38216200 Free PMC article.

9

Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.

Al-Hendy A, Lee EJ, Wang HQ, Copland JA. Al-Hendy A, et al. Am J Obstet Gynecol. 2004 Nov;191(5):1621-31. doi: 10.1016/j.ajog.2004.04.022. Am J Obstet Gynecol. 2004. PMID: 15547533

10

Gene therapy and uterine leiomyoma: a review.

Al-Hendy A, Salama S. Al-Hendy A, et al. Hum Reprod Update. 2006 Jul-Aug;12(4):385-400. doi: 10.1093/humupd/dml015. Epub 2006 Apr 7. Hum Reprod Update. 2006. PMID: 16603566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page